FDA inspection
Samsung Biologics Co., Ltd.: FDA inspection ending May 27, 2025
FDA inspection 1269570 · Yeonsu
Key facts
| Inspection ID | 1269570 |
|---|---|
| Firm | Samsung Biologics Co., Ltd. |
| FEI number | 3010479596 |
| Address | 300 Songdobaiodae-Ro |
| City | Yeonsu |
| Fiscal year | 2025 |
| Inspection end date | May 27, 2025 |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data